ML20005A840

From kanterella
Jump to navigation Jump to search
Notice of Violation from Insp on 810616.Noncompliance Noted: Quarterly,Linearity Checks of Dose Calibrator Not Performed & Medical Isotopes Committee Meetings Held Semiannually Only
ML20005A840
Person / Time
Issue date: 06/25/1981
From: Wiedeman D
NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION III)
To:
Shared Package
ML20005A834 List:
References
NUDOCS 8107010356
Download: ML20005A840 (3)


Text

J:.

s.

Appendix A NOTICE OF VIOLATION Howard Young Medical Center License No. 48-18643-01 As a result of the inspection conducted on June 16, 1981, and in accord-ance with the Interim Enforcement Policy, 45 FR 66754 (October 7, 1980),

the following violations were identified:

1.

License Condition No. 17 requires licensed material to be possessed and used in accordance with statements, representations, and procedures contained in application dated December 20, 1978, and supplement received March 21, 1979.

a l

Application dated December 20, 1978, Item No. 10 states that the procedures described in Appendix D, Section 2 of the NRC Medical Licensing Guide will be used for the calibration of the dose calibrator.

Appendix D, Section 2 requires that daily-constancy, quarterly linearity and annual accuracy checks of the dose calibrator be performed and re--

corded.

Contrary to the above requirement, qusrterly linearity checks of the dose calibrator were not performed.

This is a Severity Level V violation (Supplement VII).

2.

License Condition No. 17 requires licensed material to be possessed and used in accordance with statements, representations, and procedures contained in application dated December 20, 1978, and supplement received March 21, 1979.

Application dated December 20, 1978, Item No. 7 states that the duties of the medical isotope committee will be as described in Appendix B of the NRC Medical Licensing Guide. Appendix B states that the medical isotopes committee shall meet as of ten as necessary to conduct its business but not less than once each calendar quarter.

I Contrary to the above requirement, the medical isotopes committee meetings were being held on a semi-annual basis only.

This is a Severity Level V violation (Supplement VII).

t 810'I 010 3.f(,

O' va 6

Appendix A 3.

License Ccudition No. 17 requires licensed material to be possessed and used in accordance with statements, representations, and procedures contained in application dated December 20, 1978, and supplement received March 21, 1979.

Application dated December 20, 1978, Item No. 14 states that the procedures described in Appendix F, of the NRC Medical Licensing Guide, for safe opening of packages containing radioactive materials will be followed. Appendix F states that packages containing radioactive materials must be surveyed at a distance of three feet and at the surface of the package prior to opening.

Contrary to the above requirement, packages containing radioactive materials were not being surveyed.

This is a Severity Level V violation (Supplement VII).

4.

License Condition No. 17 requires licensed material to be possessed and used in accordance with statements, representations, and procedures contained in application dated December 20, 1978, and supplement received March 21, 1979.

Application dated December 20, 1978, Item No. 17 states that area surveys will be performed according to Appendix I of the NRC Medical Licensing Guide. Appendix I states that a series of wire tests to measure contamination levels must be performed.

Contrary to the above requirement, wipe tests to measure contamina-tion levels were not being performed.

This is a Severity Level V violation (Supplement VII).

5.

10 CFR 30.51(b) requires that records of receipt, transfer, and dis-posal of byproduct material be maintained for the period specified by the appropriate regulation or license condition.

v.

Contrary to the above, records of receipt and transfer of iodine-131 capsules were not being maintained.

This is a Severity Level VI violation (Supplement VII).

6.

10 CFR 35.14(b)(5)(i) states that each source or device containing more than 100 microcuries of byproduct material with a half-life greater than thirty days must be tested for contamination and/or leakage at intervals not to exceed six months.

Contrary to the above, the barium-133 and cesium-137 sources, having activ. ties more than 100 microcuries were not being tested for con-tamination and/or leakage since the issuance of the license.

This is a Severity Level V violation (Supplement VII).

l

n.-

~

I Appendix A 3-Pursuant to the provisions of 10 CFR 2.201, you are required to submit to this office within thirty days of the date of this Notice a written statement or explanation in reply, including for each item of noncompliance:

(1) cor-rective action taken and the results achieved; (2) corrective action to be taken to avoid further noncompliance; and (3) the date when full compliance will be achieved. Under the authority of Section= 182 of the Atomic Energy Act of 1954, as amended, this response shall be submitted under oath or affirmation. Consideration may be given to extending your response time for good cause shown.

-9 G/ F f/

M=

Dated '

f D. 'G. Wiedeman, Acting Chief Materials Radiation Protection Section 1 I

l l

,,iw-w w

- - y y

.v-r

-w------

- -r, r,

w-w r-+-

-